IP Verse

New Treatments With Triazines - EP2928454

The patent EP2928454 was granted to Ceva Sant Animale on Mar 18, 2020. The application was originally filed on Dec 6, 2013 under application number EP13802596A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2928454

CEVA SANT ANIMALE
Application Number
EP13802596A
Filing Date
Dec 6, 2013
Status
Granted And Under Opposition
Feb 14, 2020
Grant Date
Mar 18, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELANCODec 18, 2020POTTER CLARKSONWITHDRAWN
BAYER ANIMAL HEALTHMar 18, 2020VON RENESSEWITHDRAWN

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTDE102007025908
INTERNATIONAL-SEARCH-REPORTUS6465460
INTERNATIONAL-SEARCH-REPORTWO0214288
OPPOSITIONCA2688613
OPPOSITIONCN101947201
OPPOSITIONCN102512366
OPPOSITIONCN102743334
OPPOSITIONDE102007025908
OPPOSITIONEP2164496
OPPOSITIONEP2276347
OPPOSITIONUS2010179151
OPPOSITIONUS3536696
OPPOSITIONWO0019964
OPPOSITIONWO2010146155
OPPOSITIONWO2014086958
OPPOSITIONWO2019233870
OTHERCN102743334
OTHEREP2164496
OTHERUS6465460

Non-Patent Literature (NPL) Citations (31) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- anonymous, "Baycox 5%® ad us. vet., orale Suspension", CliniPharm CliniTox, (20080900), URL: https://www.vetpharm.uzh.ch/TAK/05000000/00056127.01, (20200422), XP055706737-
OPPOSITION- Anonymous, "Composition", Webster Comprehensive Dictionary, (19920101), XP093001070-
OPPOSITION- Anonymous, "CVMP assessment report for Forceris (EMEA/V/C/004329/0000) International non-proprietary name: toltrazuril/ iron (iii) ion", CVMP assessment report for Forceris (EMEA/V/C/004329/0000) EMA/138662/2019, European Medicines Agency, (20190221), pages 1 - 37, XP055605322-
OPPOSITION- Anonymous, "GUIDELINE ON PHARMACEUTICAL FIXED COMBINATION PRODUCTS", EMEA1, (20060101), EMEA1, (20221123), XP093001074-
OPPOSITION- Anonymous, "Stop Coccidiosis in Piglets!", BAYCOX, (20030101), XP093001056-
OPPOSITION- Anonymous, "THE LONDON GAZETTE", (19780505), (20221123), XP093001076-
OPPOSITION- Anonymous, "Uniferon iron(III)Dextran", Uniferon, (20201215), Uniferon, (20221123), XP093001063-
OPPOSITION- Banker, Et Al., "Modern Pharmaceutics second edition", (19890101), (20221123), XP093001067-
OPPOSITION- "Coccidiosis", Salsbury Laboratories, Salsbury Manual of Poultry Diseases, (19820000), pages 13 - 15, XP055706779-
OPPOSITION- ECKERT J. et al., Lehrbuch der Parasitologie für Tiermedizin, Stuttgart, Enke Verlag, (20080000), page 611, XP055706770-
OPPOSITION- "Eisenmangelanämie", HEINRITZI K. et al., Schweinekrankheiten, Stuttgart, UTB, (20060000), pages 52 - 54, XP055702028-
OPPOSITION- Griessler, Voglmayr, Holzheu, Werner-Tutschku, "Schweinekrankheiten - Erkennen und erfolgreich behandeln (auszug)", Schweinekrankheiten - Erkennen und erfolgreich behandeln, (20080101), pages 92 - 93, XP055825082-
OPPOSITION- Haberkorn A., J. Stoltefuss, "Studies on the Activity Spectrum of Toltrazuril*, a New Anti-Coccidial Agent", VMR, Veterinary medical review, (19870101), vol. 1, ISSN 0341-9851, pages 22 - 32, XP055825026-
OPPOSITION- Heinritzi Karl, Hans Rudolf Gindele, Gerald Reiner, Ute Schnurrbusch, "Schweinekrankheiten (auszug)", Schweinekrankheiten, (20060101), pages 44 - 46, XP055825076-
OPPOSITION- "Iron dextran", CAS, (19841116), Database accession no. 9004-66-4, URL: STN, XP055706721-
OPPOSITION- "Kokzidiose", HEINRITZI K. et al., Schweinekrankheiten, Stuttgart, Eugen Ulmer KG, (20060000), pages 165 - 166, XP055679151-
OPPOSITION- Michael E Aulton, "Pharmaceutics: The Science of Dosage Form Design. Excerpt", (19880101), pages 1 - 173, XP055734912-
OPPOSITION- MO, Q., "Modern pig farming - pig farming front line - what kind of diseases occur in pigs between summer and autumn", Animal Husbandry in the North, (20080915), XP055706716-
OPPOSITION- MUNDT H.C et al., "Efficacy of a Bycox® plus iron suspension formulation for the control of neonatal porcine coccidiosis", 22nd International Pig Veterinary Society Congress (IPVS 2012 Korea), Jeju, Korea, (20120601), page 552, XP055679160-
OPPOSITION- MURIEL NACIRI, "Coccidiosis in chicken", INRA BAYER Handbook, (20000000), XP055706872-
OPPOSITION- N/a, "Baycox® 5% - Toltrazuril Coccidiocide for piglets - Technical information sheet", Bayer AG, (20030101), pages 1 - 31, Bayer AG, URL: http://avipharm.co.za/wp-content/uploads/2011/04/Baycox-5%25.pdf , (20180222), XP055453605-
OPPOSITION- Norman D. Levine, "Eimeria, Chicken", Norman D. Levine, PETER L. LONG, The Biology of the Coccidia, University Park Press, (19820000), page 15, 28, XP055706878-
OPPOSITION- "Parasitis Diseases. Coccidiosis", JORDAN F. T. W. et al., Poultry Diseases. 4th ed., W. B. Saunders, (19960000), pages 261 - 267, XP055706783-
OPPOSITION- "Protozoa", ECKERT J. et al., Lehrbuch der Parasitologie für Tiermedizin, Stuttgart, Enke Verlag, (20080000), pages 82 - 83, XP055679156-
OPPOSITION- Salle E., V. Auvigne, "Comparative Study of the Efficacy of Gleptoferron and Iron Dextran in Anaemia Prevention in Piglets", Proceedings of the 19th IPVS Congress, Copenhagen, Denmark, Copenhagen, Denmark , (20060101), vol. 2, page 567, XP055825110-
OPPOSITION- Taylor D J, "PIG DISEASES Sixth edition", PIG DISEASES Sixth edition, ST Edmundsbury Press, (19950101), pages 274 - 277, XP055954627-
OPPOSITION- Taylor D.J., "Piglet enteritis from 10 days to weaning", PIG JOURNAL, PIG VETERINARY SOCIETY, WILTS, GB, GB , (19970101), vol. 36, ISSN 1352-9749, pages 158 - 174, XP055825043-
OPPOSITION- "Ursoferran® 200 mg/ml (Prolongal 200 mg/ml)", Summary of Product Characteristics, (20050819), XP055706729-
OPPOSITION- Waldmann, Et Al., "Chapters 4, 9 and 13", Lehrbuch der Schweinekrankheiten, (20010101), pages 49 - 188-192,369-371, XP055954836-
OPPOSITION- Waldmann Karl-Heinz, Michael Wendt, "LEHRBUCH DER SCHWEINEKRANKHEITEN (auszug)", LEHRBUCH DER SCHWEINEKRANKHEITEN, 3. Auflage, (20010101), pages 49 - 192, 369-371, XP055825053-
OPPOSITION- H ABERKORN et al., "Animal Models of Coccidia Infection", Handbook of Animal Models of Infection, (19990000), pages 821 - 838, XP055706790

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents